Distinguished in Wilson Disease

Pierre-jean J. Saulnier

Poitiers, FR 
Distinguished in Wilson Disease
Poitiers, FR 
OverviewLocationsClinical Research

Overview

Pierre-jean Saulnier practices in Poitiers, France. Saulnier is rated as a Distinguished expert by MediFind in the treatment of Wilson Disease. Their top areas of expertise are Diabetic Nephropathy, Type 2 Diabetes (T2D), Wilson Disease, Maturity Onset Diabetes of the Young, and Kidney Transplant.

Their clinical research consists of co-authoring 101 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 22 articles and participated in 1 clinical trial in the study of Wilson Disease.

Locations

Poitiers, France
Other Locations
Angers, 49000, France
2 Rue De La Milétrie, Vienne, 86000, France
France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Enrollment Status: Terminated
Publish Date: April 09, 2025
Intervention Type: Other
Study Phase: Not Applicable
Advancing Tools for Human Early Lifecourse Exposome Research and Translation- Adolescence Follow-up of the HELIX Subcohort
Advancing Tools for Human Early Lifecourse Exposome Research and Translation- Adolescence Follow-up of the HELIX Subcohort
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

101 Total Publications

Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetes.
Fasting urine osmolality and risk of kidney disease progression in patients with type 2 diabetes.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: December 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Saulnier's expertise for a condition
ConditionClose
    View All 14 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile